[go: up one dir, main page]

FR17C1011I1 - - Google Patents

Info

Publication number
FR17C1011I1
FR17C1011I1 FR17C1011C FR17C1011I1 FR 17C1011 I1 FR17C1011 I1 FR 17C1011I1 FR 17C1011 C FR17C1011 C FR 17C1011C FR 17C1011 I1 FR17C1011 I1 FR 17C1011I1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38691782&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR17C1011(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of FR17C1011I1 publication Critical patent/FR17C1011I1/fr
Application granted granted Critical
Publication of FR17C1011I2 publication Critical patent/FR17C1011I2/en
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/69Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR17C1011C 2007-08-06 2017-04-14 PROTEASOME INHIBITORS Active FR17C1011I2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2007/017440 WO2009020448A1 (en) 2007-08-06 2007-08-06 Proteasome inhibitors

Publications (2)

Publication Number Publication Date
FR17C1011I1 true FR17C1011I1 (en) 2017-05-26
FR17C1011I2 FR17C1011I2 (en) 2018-04-27

Family

ID=38691782

Family Applications (1)

Application Number Title Priority Date Filing Date
FR17C1011C Active FR17C1011I2 (en) 2007-08-06 2017-04-14 PROTEASOME INHIBITORS

Country Status (32)

Country Link
EP (3) EP2178888B1 (en)
JP (1) JP5261488B2 (en)
KR (6) KR20160040735A (en)
CN (1) CN101772507B (en)
AU (1) AU2007357338B2 (en)
BR (1) BRPI0721905B8 (en)
CA (1) CA2695082C (en)
CY (2) CY1113386T1 (en)
DK (1) DK2178888T3 (en)
EA (1) EA028622B1 (en)
EC (1) ECSP10010015A (en)
ES (1) ES2390606T3 (en)
FR (1) FR17C1011I2 (en)
GE (1) GEP20125599B (en)
HR (1) HRP20120745T1 (en)
HU (1) HUS1700018I1 (en)
IL (4) IL203641A (en)
LT (1) LTC2178888I2 (en)
LU (1) LUC00013I2 (en)
MY (1) MY161991A (en)
NL (1) NL300871I2 (en)
NZ (1) NZ582693A (en)
PH (1) PH12014500053B1 (en)
PL (1) PL2178888T3 (en)
PT (1) PT2178888E (en)
RS (1) RS52435B (en)
SG (1) SG10201508712QA (en)
SI (1) SI2178888T1 (en)
TN (1) TN2010000060A1 (en)
UA (1) UA97536C2 (en)
WO (1) WO2009020448A1 (en)
ZA (1) ZA201000348B (en)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7576206B2 (en) 2003-08-14 2009-08-18 Cephalon, Inc. Proteasome inhibitors and methods of using the same
US7468383B2 (en) 2005-02-11 2008-12-23 Cephalon, Inc. Proteasome inhibitors and methods of using the same
JP5436860B2 (en) 2005-11-09 2014-03-05 オニキス セラピューティクス, インク. Compounds for enzyme inhibition
WO2007149512A2 (en) 2006-06-19 2007-12-27 Proteolix, Inc. Peptide epoxyketones for pr0teas0me inhibition
US7442830B1 (en) 2007-08-06 2008-10-28 Millenium Pharmaceuticals, Inc. Proteasome inhibitors
MY173938A (en) 2007-10-04 2020-02-27 Onyx Therapeutics Inc Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides
PT2730581T (en) 2008-06-17 2016-08-17 Millennium Pharm Inc Boronate ester compounds and pharmaceutical compositions thereof
AR075090A1 (en) 2008-09-29 2011-03-09 Millennium Pharm Inc ACID DERIVATIVES 1-AMINO-2-CYCLLOBUTILETILBORONICO PROTEOSOMA INHIBITORS, USEFUL AS ANTI-BANKER AGENTS, AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM.
AU2009308516B2 (en) 2008-10-21 2016-08-25 Onyx Therapeutics, Inc. Combination therapy with peptide epoxyketones
AR075899A1 (en) 2009-03-20 2011-05-04 Onyx Therapeutics Inc PROTEASA INHIBITING CRYSTALLINE EPOXYCETON TRIPEPTIDES
US8853147B2 (en) 2009-11-13 2014-10-07 Onyx Therapeutics, Inc. Use of peptide epoxyketones for metastasis suppression
CA2785300A1 (en) 2009-12-22 2011-07-21 Cephalon, Inc. Proteasome inhibitors and processes for their preparation, purification and use
BR112012022060A2 (en) 2010-03-01 2018-05-08 Onyx Therapeutics Inc compound for inhibition of immunoproteasome
MX2012011298A (en) 2010-03-31 2012-11-06 Millennium Pharm Inc Derivatives of 1-amino-2-cyclopropylethylboronic acid.
CA2833775A1 (en) * 2011-06-22 2012-12-27 Cephalon, Inc. Proteasome inhibitors and processes for their preparation, purification and use
CN108383893A (en) * 2011-08-30 2018-08-10 塔夫茨大学信托人 The proteasome inhibitor that FAP- for treating solid tumor is activated
EA201400735A1 (en) * 2011-12-22 2015-04-30 Арес Трейдинг С.А. DERIVATIVES ALPHA-AMINO BORONIC ACID, SELECTIVE INHIBITORS IMMUNOPROTEASOMA
EP2812338A4 (en) * 2012-01-24 2015-09-23 Millennium Pharm Inc METHOD OF TREATING NASOPHARYNGEAL CANCER
EP2810066B1 (en) * 2012-01-24 2019-07-31 Millennium Pharmaceuticals, Inc. Methods of treatment of cancer
US20140105921A1 (en) 2012-07-09 2014-04-17 Onyx Therapeutics, Inc. Prodrugs of Peptide Epoxy Ketone Protease Inhibitors
CN103570806B (en) * 2012-07-26 2020-04-07 圣特莱国际公司 Polypeptide epoxy ketone compound
JP2013006855A (en) * 2012-09-03 2013-01-10 Millennium Pharmaceuticals Inc Proteasome inhibitor
JP6018319B2 (en) * 2012-12-03 2016-11-02 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Substituted triazole boronic acid compounds
US20160250238A1 (en) * 2013-10-03 2016-09-01 Millennium Pharmaceuticals, Inc. Method for the Prophylaxis or Treatment of Systemic Lupus Erythematosus and/or Lupus Nephritis
US20150335668A1 (en) 2014-05-20 2015-11-26 Millennium Pharmaceuticals, Inc. Method for cancer therapy
EP3177292B1 (en) 2014-08-07 2020-11-25 Mayo Foundation for Medical Education and Research Compounds and methods for treating cancer
MA41555A (en) * 2015-02-17 2017-12-26 Millennium Pharm Inc POLYTHERAPY FOR CANCER TREATMENT
WO2016205790A2 (en) 2015-06-19 2016-12-22 Hanlin Scientific, Inc. Chiral specific boron-containing compounds and their use in treating cancer or amyloidosis
CN106608883A (en) * 2015-10-21 2017-05-03 北京大学 Synthetic method of proteasome inhibitor MLN9708
WO2017198194A1 (en) * 2016-05-19 2017-11-23 成都奥璟生物科技有限公司 Boronic acid and borate ester compound and applications thereof
CN106008572B (en) * 2016-05-23 2018-08-17 成都千禧莱医药科技有限公司 A kind of dipeptide boronic acid compound and preparation method and purposes
EP3472151A4 (en) 2016-06-21 2020-03-04 Orion Ophthalmology LLC CARBOCYCLIC PROLINAMIDE DERIVATIVES
JP7179721B2 (en) 2016-06-21 2022-11-29 オリオン・オフサルモロジー・エルエルシー Heterocyclic prolinamide derivative
WO2018019196A1 (en) * 2016-07-25 2018-02-01 深圳市塔吉瑞生物医药有限公司 Substituted boric acid compound, pharmaceutical composition comprising same, and application thereof
CN108440583B (en) * 2017-01-23 2020-12-04 成都奥璟生物科技有限公司 Boric acid derivative and its medicinal composition
US11596629B2 (en) 2017-02-28 2023-03-07 Mayo Foundation For Medical Education And Research Compounds and methods for treating cancer
CN108794516A (en) * 2017-04-26 2018-11-13 上海时莱生物技术有限公司 Boric acid and boric acid ester compound and its preparation method and application
CN109305980B (en) * 2017-07-28 2022-10-11 成都奥璟生物科技有限公司 Borate compound, and synthesis method and application thereof
ES2901022T3 (en) 2017-08-25 2022-03-21 Synthon Bv Procedure for the preparation of ixazomib and its intermediates
JP2018024694A (en) * 2017-10-03 2018-02-15 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. Proteasome inhibitor
US11243207B2 (en) 2018-03-29 2022-02-08 Mayo Foundation For Medical Education And Research Assessing and treating cancer
CN115403603A (en) * 2018-09-14 2022-11-29 成都奥璟生物科技有限公司 Boric acid ester medicine and application thereof
CN110357787A (en) * 2019-08-02 2019-10-22 苏州艾和医药科技有限公司 Yi Shazuo meter synthesising process research
US20220362268A1 (en) * 2019-10-07 2022-11-17 Cornell University Antimicrobial and antiviral effects of c2-c7 alkyl boronic acids
CN110950897B (en) * 2019-12-12 2021-05-28 山东大学 A kind of histone deacetylase, proteasome dual-target inhibitor and preparation method and application thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4499082A (en) 1983-12-05 1985-02-12 E. I. Du Pont De Nemours And Company α-Aminoboronic acid peptides
US5187157A (en) 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
US5250720A (en) 1987-06-05 1993-10-05 The Dupont Merck Pharmaceutical Company Intermediates for preparing peptide boronic acid inhibitors of trypsin-like proteases
US5242904A (en) 1987-06-05 1993-09-07 The Dupont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
EP0315574A3 (en) 1987-11-05 1990-08-22 Hoechst Aktiengesellschaft Renin inhibitors
US5106948A (en) 1988-05-27 1992-04-21 Mao Foundation For Medical Education And Research Cytotoxic boronic acid peptide analogs
US6083903A (en) * 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
EP2251344B2 (en) 2001-01-25 2024-04-24 THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Formulation of boronic acid compounds
ATE317850T1 (en) 2001-05-30 2006-03-15 Novartis Pharma Gmbh 2-((N-(2-AMINO-3-(HETEROARYL- OR - ARYL)PROPIONYL)AMINOACYL)AMINO)- ALKYLBORONIC ACID DERIVATIVES
UA88771C2 (en) * 2003-08-14 2009-11-25 Сефалон, Инк. Proteasome inhibitors and methods of using the same (variants)
US7223745B2 (en) 2003-08-14 2007-05-29 Cephalon, Inc. Proteasome inhibitors and methods of using the same
US7576206B2 (en) 2003-08-14 2009-08-18 Cephalon, Inc. Proteasome inhibitors and methods of using the same
WO2005097809A2 (en) * 2004-03-30 2005-10-20 Millennium Pharmaceuticals, Inc. Synthesis of boronic ester and acid compounds
WO2006008660A2 (en) 2004-07-20 2006-01-26 Affinium Pharmaceuticals, Inc. Streptococcus pneumoniae enoyl- (acyl-carrier-protein) reductase (fabk)
TW200618820A (en) * 2004-11-05 2006-06-16 Alza Corp Liposome formulations of boronic acid compounds
GB0513349D0 (en) 2005-06-29 2005-08-03 Torres Manel Non-woven fabric
CN101247799B (en) 2005-07-05 2013-03-27 塔夫茨大学信托人 Inhibitors of fibroblast activation protein alpha

Also Published As

Publication number Publication date
CY1113386T1 (en) 2016-06-22
EA201070247A1 (en) 2010-06-30
CA2695082A1 (en) 2009-02-12
CY2017016I1 (en) 2017-07-12
LUC00013I2 (en) 2017-06-19
SG10201508712QA (en) 2015-11-27
KR20150010802A (en) 2015-01-28
EP2527347A1 (en) 2012-11-28
IL242290A0 (en) 2015-11-30
SI2178888T1 (en) 2012-11-30
KR20160040735A (en) 2016-04-14
KR20140042932A (en) 2014-04-07
LUC00013I1 (en) 2017-04-06
BRPI0721905A2 (en) 2014-02-25
ES2390606T3 (en) 2012-11-14
BRPI0721905B8 (en) 2021-05-25
IL242292A0 (en) 2015-11-30
IL242291A0 (en) 2015-11-30
HUS1700018I1 (en) 2017-05-29
KR101831674B1 (en) 2018-02-23
EP3210987A1 (en) 2017-08-30
LTC2178888I2 (en) 2018-03-12
ECSP10010015A (en) 2010-04-30
KR101474831B1 (en) 2014-12-19
CA2695082C (en) 2015-07-28
LTPA2017010I1 (en) 2017-05-10
HK1182924A1 (en) 2013-12-13
EP2178888B1 (en) 2012-07-04
NZ582693A (en) 2012-01-12
IL242290A (en) 2017-12-31
PH12014500053A1 (en) 2015-03-30
HRP20120745T1 (en) 2012-10-31
IL242292A (en) 2017-12-31
RS52435B (en) 2013-02-28
JP2010535759A (en) 2010-11-25
WO2009020448A1 (en) 2009-02-12
PT2178888E (en) 2012-10-04
BRPI0721905B1 (en) 2020-11-17
IL203641A (en) 2015-11-30
KR20170004031A (en) 2017-01-10
ZA201000348B (en) 2011-03-30
CN101772507B (en) 2012-12-12
PH12014500053B1 (en) 2015-03-30
IL242291A (en) 2017-12-31
CN101772507A (en) 2010-07-07
KR20100059811A (en) 2010-06-04
AU2007357338B2 (en) 2014-03-20
CY2017016I2 (en) 2017-07-12
TN2010000060A1 (en) 2011-09-26
EP2178888A1 (en) 2010-04-28
DK2178888T3 (en) 2012-10-01
JP5261488B2 (en) 2013-08-14
NL300871I2 (en) 2017-12-07
HK1143595A1 (en) 2011-01-07
EA028622B1 (en) 2017-12-29
KR20140042933A (en) 2014-04-07
GEP20125599B (en) 2012-08-10
PL2178888T3 (en) 2012-11-30
UA97536C2 (en) 2012-02-27
FR17C1011I2 (en) 2018-04-27
MY161991A (en) 2017-05-31
AU2007357338A1 (en) 2009-02-12

Similar Documents

Publication Publication Date Title
FR17C1011I1 (en)
CN300726710S (zh) 凿柄(1)
CN300807544S (zh) 引流袋
CN300727567S (zh) 数码录音笔(vm420)
CN300727531S (zh) 墙壁开关(efnd100a)
CN300863403S (zh) 印花布(186)
CN300850812S (zh) 服装(80)
CN300827267S (zh) 包装盒
CN300809282S (zh) 铅笔包装袋(364)
CN300727420S (zh) 驾驶室侧位内饰
CN300727342S (zh) 摩托车卡子
CN300727193S (zh) 酒瓶盖(a128)
CN300727161S (zh) 食品包装纸(唐僧)
CN300726518S (zh) 床头(909)
CN300727151S (zh) 包装袋(魔力钾)
CN300726997S (zh) 集装箱
CN300799126S (zh) 面料(4)
CN300726988S (zh) 包装盒(氢化可的松注射液)
CN300726936S (zh) 包装盒(不裂神乳霜)
CN300726910S (zh) 包装盒
CN300726905S (zh) 食品包装盒(如咽口香糖)
CN300726724S (zh) 螺丝刀(多功能qc-179)
CN300795279S (zh) 门电机
CN300728407S (zh) 吸顶灯(1)
CN300726685S (zh) 洗衣板(鱼形)